PBD News and Press, Invesco Global Clean Energy From 12/30/20

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease Phase III BRIDGE open-label, switch-over clinical trial met key objective...

ICLN may be the best ETF to capture the growing renewable energy trend. The strong and growing renewable energy trend is supported by Biden’s climate policies, increased global adoptions, and cheaper renewable electricity cost. COVID-19 further pushed ESG conscious investor...

Many analysts believe that fossil fuel use has peaked. Alternative energy continues to take more share in terms of more EVs on the road and more solar and wind installations. PBW, QCLN, TAN, and PBD are four cleantech ETFs for investors to consider. A political shift in the US favors c...

Clean and renewable energy is the future. Fossil fuel consumption may already have peaked. Younger generations prioritize taking care of the environment, so investors should look to build positions in the "future of energy". Four ETFs investors should consider are QCLN, PBW, TAN, and PBD. ...

ALPS Clean Energy ETF provides us its take on the ever-popular alternative energy ETF. Resolutely North American in its make-up, its purpose is to afford investors exposure to renewables such as solar, wind, hydropower, and biofuels. Part of an immensely popular renewable energy t...

Hydrogen has been proposed to provide grid scale energy storage, replacing natural gas to power a net-zero carbon electric grid. The increasing preference for net-zero carbon status among institutional investors, and the increasingly stringent regulatory constraints, motivate these ef...

Invesco Global Clean Energy ETF capitalizes on the drive surrounding alternative energy sources – a thematic play presently in vogue with investors. And with expense fees at 0.75%, it makes investors pay for the privilege given the fund's standard characteristics. Alternati...

An impressive performance in PBD since late 2018. Rejoining the Paris climate accords strengthens the case for PBD. The shares did better under the Trump administration than under the Obama administration. The trend towards responsible investing is bullish for PBD. A pullb...

Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Extension of PDUFA Date for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease PR Newswire CARMIEL, Israel, Nov. 27, 2020 CARMIEL, Israel , Nov. 27, 2020 /PRNewswire/ -- Protalix ...

The Ardour Global Alternative Energy Extra-Liquid Index (AGIXL) can provide investors with broad, globally-inclusive alternative energy exposure with the benefit of a liquidity screen. Alternative energy is positioned to become an increasingly important part of the global energy lands...